JOHNSON & JOHNSON is 388.1x more valuable than CAPRICOR THERAPEUTICS, INC. by market capitalization ($579.83 B vs $1.49 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CAPR | JNJ |
|---|---|---|
| Market cap | $1.49 B | $579.83 B |
| US-listed rank | #2343 | #20 |
| Revenue (latest FY) | $0.00 | $94.19B |
| Net income (latest FY) | -$105.04M | $26.80B |
| Net margin | - | 28.5% |
| P/E (trailing FY) | - | 21.6 |
| SEC filings | 943 | 984 |
JOHNSON & JOHNSON is 388.1x more valuable than CAPRICOR THERAPEUTICS, INC. by market capitalization ($579.83 B vs $1.49 B).
In their latest fiscal years, CAPRICOR THERAPEUTICS, INC. reported $0.00 in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: CAPRICOR THERAPEUTICS, INC. and JOHNSON & JOHNSON, or browse the full rankings.